Ebola treatment trials begin in Ituri, DRC
Compare the reporting
Discrepancy in death toll and case count.
Open the listed sources to review each publisher’s original wording.
Story essentials
World Health Organization (WHO), INRB, and medical researchers
Ituri region, Democratic Republic of the Congo
July 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 17/12/2026, 3:31:06 PM
Clinical trials for two Ebola drugs, remdesivir and MBP134, have commenced in the Ituri region. The trial aims to reduce mortality rates for the Bundibugyo strain of the virus. As of July 9, 1,792 confirmed cases and 625 deaths have been reported. Frontline workers are protesting due to lack of financial support, complicating the response.
Read next
Prioritized by shared people, places, and events.
Ebola outbreak in DRC
Pope Leo XIV has called for greater international mobilization to combat the Ebola outbreak in the DRC. The outbreak has claimed over 2,500 lives. The Pope urged increased support and local community involvement.